Latest news with #Ispire
The Star
6 hours ago
- Business
- The Star
Cabinet to decide on cannabis vape factory issue, says Health Minister
KUALA LUMPUR: The Cabinet will make a collective decision regarding the controversy surrounding a US-based vape company manufacturing "cannabis hardware" in Johor, says Health Minister Datuk Seri Dr Dzulkefly Ahmad. "I will address this issue later. We have to present it to the Cabinet and from there, we will make a collective decision," he said. He added that several ministries and agencies are involved, such as the Investment, Trade and Industry Ministry, the Malaysian Investment Development Authority among others. "So, we will table this in the Cabinet meeting and reach a collective decision," said Dr Dzulkefly after attending the opening ceremony of the 31st Association of Private Hospitals Malaysia (APHM) conference at the KL Convention Centre on Monday (June 9). On Thursday (June 5), Perikatan Nasional health committee chair Dr Ahmad Yunus Hairi called for a police investigation into the vape factory in Senai, Johor operated by Ispire Technology Inc, a Nasdaq-listed company based in California, US. "The manufacturing licence for Ispire's factory in Senai was issued by Mida. However, questions arose as to whether Mida approvals cover the manufacturing of cannabis-related products, which is clearly illegal under the Dangerous Drugs Act 1952," said the Kuala Langat MP. The licence granted by Mida to Ispire is touted as Malaysia's first federal licence to produce nicotine products. The sale of nicotine liquids is regulated under the Control of Smoking Products for Public Health Act.
Associated Press
6 days ago
- Business
- Associated Press
Ispire-Backed IKE Tech to Present 7th Annual Next Generation Nicotine Delivery USA Conference
Conference Attendance Follows Groundbreaking FDA PMTA Filing for Blockchain-Powered Age-Gating System LOS ANGELES, June 3, 2025 /PRNewswire/ -- Ispire Technology Inc. ('Ispire' or the 'Company') ( NASDAQ: ISPR ), a trailblazer in vaping technology and precision dosing, announced that IKE Tech LLC ('IKE Tech'), a joint venture that includes Ispire as a founding partner, will showcase their technology at the 7th Annual Next Generation Nicotine Delivery USA at the Hyatt Regency in Miami from June 4-5th. This event convenes key business leaders from the FDA, the ENDS (Electronic Nicotine Delivery Systems) sector, and the tobacco industry across the U.S. market to explore strategies for legal compliance and commercial success. The announcement comes on the heels of IKE Tech's historic milestone, in which the joint venture filed a component Pre-Market Tobacco Product Application (PMTA) and Tobacco Product Master File (TPMF) with the U.S. Food and Drug Administration (FDA) for its Bluetooth Low Energy (BLE) System-on-a-Chip. IKE Tech has now received an Acceptance Review letter from the FDA, confirming that their PMTA meets regulatory requirements to be accepted, and moves the application into the FDA's filing review phase. This marked the first-ever complete PMTA submission for a standalone, interoperable, blockchain-enabled age-verification component designed for universal integration across all ENDS devices. Unlike traditional systems that verify age only at the point of purchase, IKE Tech's platform requires continuous, real-time identity verification, offering an unprecedented level of security against underage vaping. IKE has formally requested expedited review of the application, citing its potential to significantly enhance public health. At the conference, John Patterson, senior vice president of International Nicotine at Ispire and president of IKE Tech, will speak on a panel titled " Technology to End Youth Vaping for Electronic Nicotine Delivery Systems,' scheduled for Wednesday, June 4, at 2:00 p.m. In his capacity as President of IKE Tech, Patterson will discuss: To schedule a meeting with John Patterson or other Ispire representatives, please email [email protected]. About IKE Tech LLC IKE Tech LLC is a joint venture comprised of three leading technology and research companies -- Ispire Technology Inc, Touch Point Worldwide Inc. d/b/a Berify, and Chemular Inc. -- dedicated to revolutionizing Identity and Age Verification (IAV) technology solutions. Recognizing the absence of a universal point-of-sale IAV solution and recognition of the need for one, these companies joined forces to create a unique IAV technology component. IKE's mission is to set the gold standard for IAV by (i) permitting access to electronic nicotine delivery systems by authorized adult users while (ii) preventing underage access through a 'plug and play' component compatible across different devices and platforms. About Ispire Technology Inc. Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit or follow Ispire on Instagram, LinkedIn, Twitter and YouTube. Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ('Securities Act') as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as 'believe,' 'expect,' 'may,' 'will,' 'should,' 'would,' 'could,' 'seek,' 'intend,' 'plan,' 'goal,' 'project,' 'estimate,' 'anticipate,' 'strategy,' 'future,' 'likely' or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE's success of meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in 'Risk Factors,' 'Management's Discussion and Analysis of Financial Condition and Results of Operations,' 'Cautionary Note on Forward-Looking Statements' and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the U.S. Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect. IR Contacts: For more information, kindly contact: Investor Relations Sherry Zheng 718.213.7386 [email protected] KCSA Strategic Communications Phil Carlson 212.896.1233 [email protected] PR Contact: Ellen Mellody 570.209.2947 [email protected] View original content: SOURCE Ispire Technology Inc.
Yahoo
27-05-2025
- Business
- Yahoo
Ispire Technology Inc. Announces Approval of Interim License for Manufacturing of Nicotine Products in Malaysia
Interim License Approved in May, with Authority to Begin Manufacturing of Nicotine Products in Malaysia Immediately LOS ANGELES, May 22, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced it has received the interim license from the Malaysian Government for the manufacturing of nicotine products. This is the first and only nicotine manufacturing license issued in Malaysia approved by both the Federal and State authorities and cements Ispire's position as the only company with full authorization for export, import, and production. The approval of the interim license also allows the Company to begin manufacturing nicotine products in Malaysia immediately, as well as officially begin marketing its nicotine manufacturing capabilities externally. "Receiving the interim license for our Malaysian manufacturing operations is a significant milestone for Ispire as we progress towards positioning the Company as a leading international provider of vaping hardware," said Michael Wang, Co-Chief Executive Officer of Ispire. "We can now officially begin manufacturing and marketing our nicotine products in Malaysia, with our Malaysian facility soon featuring 80 production lines, growing its capacity from the current six lines. Once the final license is approved in the coming months as we anticipate, our regulatory requirements in Malaysia will be complete and Ispire will have the first federal nicotine manufacturing license in the country. By diversifying our production base, we are strategically de-risking our production strategy and mitigating the concern of geopolitical factors increasing our pricing." About Ispire Technology is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 200 patents received or filed globally. Ispire's tobacco products are marketed under the Aspire brand name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company's cannabis products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware only in the U.S., and it recently commenced its marketing activities in Canada and Europe. For more information, visit or follow Ispire on Instagram, LinkedIn, Twitter and YouTube. Any information contained on, or that can be accessed through, the Company's website, any other website or any social media, is not a part of this press release. Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: whether the Company may be successful in re-entering the U.S. ENDS market; the approval or rejection of any PMTA submitted by the Company; whether the Company will be successful in its plans to further expand into the African market; whether the Company's joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the "Joint Venture") may be successful in achieving its goals as currently contemplated, with different terms, or at all; the Joint Venture's ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company's ability to collect its accounts receivable in a timely manner; the Company's business strategies; the ability of the Company to market to the Ispire ONE™; Ispire ONE™'s success in meeting its goals; the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of its products on the markets; the Ispire ONE™ proving to be safe; and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2024 and any subsequent filings which Ispire makes with the SEC. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect. For more information, kindly contact: IR Contacts:Investor RelationsSherry Zheng718-213-7386ir@ KCSA Strategic Communications Phil Carlson212-896-1233ispire@ PR Contact:Ellen Mellody570-209-2947EMellody@ View original content: SOURCE Ispire Technology Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11-03-2025
- Business
- Yahoo
Ispire Technology Inc. Unveils Sprout™: The Future of All-in-One Vape Technology
Ultra-Pure, Ultra-Compact, and Engineered for the Ultimate Vaping Experience in Partnership with Raw Garden LOS ANGELES, March 11, 2025 /PRNewswire/ -- Ispire Technology Inc. (Nasdaq: ISPR), a global leader in vape technology and precision dosing, announced it is setting a new benchmark in the cannabis vape industry with the launch of the Sprout™, an advanced all-in-one cannabis vapor device designed for purity, performance, and safety. Developed through a partnership with Raw Garden, Sprout™ is specifically designed to optimize the nuances and intricacies of sophisticated cannabis oil while eliminating common industry flaws like plastic degradation, clogged airflow and inconsistent heating—ensuring an experience as clean as the plant itself. Initially launching with Raw Garden, the Sprout™ technology is available to cannabis operators across the is engineered with PA12, a terpene-safe material that withstands heat and preserves cannabis purity. Unlike conventional vapes, PA12 ensures a clean and untainted vaping experience. This innovation aligns with Ispire's commitment to raising industry standards, prioritizing material safety, and putting consumer well-being first. The year-long collaboration between Ispire and Raw Garden reflects a shared commitment to innovation and consumer safety. By co-developing the Sprout™, both companies ensured that every component was meticulously engineered to maximize the integrity of the cannabis experience. "Raw Garden has always been about delivering the purest expression of the plant, and this collaboration with Ispire takes that commitment to the next level," said Michael Wang, co-CEO of Ispire. "By integrating Raw Garden's extracts with Ispire's cutting-edge hardware, we're providing consumers with a vaporizer that maximizes flavor and efficiency like never before." Key Features of Sprout™: Terpene-Safe Construction – Built with PA12, the all-in-one cannabis vape elevates the consumer experience by mitigating the impact of heat and preserving terpenes in oils from across the cannabis spectrum. Anti-Clog Overflow Chamber – Keeps airflow smooth, preventing blockages and wasted hits. Three Heat Modes – Low (2.0V), Medium (2.3V), and High (2.6V) for a customizable vaping experience. USB-C Rechargeable – No oil left behind; ensures full use of every drop. Compact and Discreet – Pocket-sized design (1.5" x 2.25") for easy portability. Dual Formulations – Available in Black Label™ Live Sauce for maximum flavor and Green Label™ Refined Live Resin for high potency. "We're thrilled to partner with Ispire. Their expertise in cutting-edge technology aligns perfectly with our shared commitment to doing right by consumers and driving meaningful innovation in this industry. Together, we're shaping the future with forward-thinking solutions," said Thomas Martin, CEO of Raw Garden."Purity in cannabis doesn't stop at the oil—it extends to everything you use to consume it," added Michael Wang. "With Sprout™, Ispire aims to redefine vape quality across the industry, and we invite other brands to adopt safer materials and improved technology, reinforcing a commitment to consumer-first innovation."Sprout™ will be available at and at select dispensaries in California, starting March 7, 2025 for more details, visit Ispire Technology is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit or follow Ispire on Instagram, LinkedIn, Twitter and YouTube. About Raw Garden:Raw Garden has been the leading producer of clean cannabis in California for over fifteen years. Raw Garden products are made from 100% single source Cannabis flower – no additives, harsh chemicals, or artificial flavors - grown outdoors in sunny Central California. The company uses entirely organically-based and Clean Green-certified farming techniques and ECCO certified practices and upholds the highest standards of transparency with all lab results freely available at Forward Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE's success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the U.S. Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect. IR Contacts:For more information, kindly contact:Investor RelationsSherry Zheng718.213.7386ir@ KCSA Strategic CommunicationPhil Carlson212.896.1233ispire@ PR Contact:Ellen Mellody570.209.2947EMellody@ View original content: SOURCE Ispire Technology Inc. Sign in to access your portfolio
